A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older
Clinical trial NCT04354480 · COMPLETED
Trial details
- NCT number
- NCT04354480
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2021-01-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.